Defined Basal Medium for Epithelial Cell Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell culture media for human mammary epithelial cells often induce stress and rapid senescence, leading to loss of lineage diversity and limited population doublings, making it challenging to maintain normal cellular phenotypes and study malignant transformations.

Innovation Solution

A defined basal medium comprising 20 naturally occurring amino acids, vitamins, trace elements, and other organics, including adenine, choline chloride, and HEPES buffer, which supports low-stress culture and maintains lineage heterogeneity for up to 60 population doublings when combined with serum and growth factors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional cell culture media are used, then cell growth is supported, but stress is induced leading to rapid senescence and loss of lineage diversity

Engineering Contradiction:
Improvecell growthVSAvoidlineage diversity maintenance
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent modifies the chemical composition parameters of the culture medium by replacing conventional components (horse serum, bovine pituitary extract) with chemically defined alternatives (insulin, hydrocortisone, epidermal growth factor, cholera toxin). This parameter change eliminates stress-inducing factors while maintaining cell growth support, allowing HMEC to maintain lineage diversity for over 60 population doublings without entering senescence.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional media are used, then initial cell proliferation is achieved, but population doublings are limited to 10-40 before senescence

Engineering Contradiction:
Improveinitial cell proliferationVSAvoidpopulation doubling capacity
Core Design Contradiction:
ProductivityVSDuration of action of moving object

Solution Approach 1:

The patent extracts and removes the harmful components from conventional media that limit cell lifespan. By eliminating horse serum and bovine pituitary extract - which contain undefined factors inducing stress and senescence - and replacing them with purified, chemically defined supplements, the medium removes the senescence-inducing elements while preserving growth-promoting functions, enabling extended population doublings beyond the conventional 10-40 limit.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a composite culture medium formulation combining multiple purified components (DMEM/F12 basal medium, insulin, hydrocortisone, epidermal growth factor, cholera toxin, transferrin, selenium) that work synergistically. This composite approach replaces the complex but harmful natural extracts with a tailored combination of purified substances, achieving both initial proliferation and extended lifespan maintenance.

Inventive Principle:
Principle #40Composite materials

3Stability of the object's composition

If chemically defined media are used, then medium composition is controlled, but lineage heterogeneity is lost and senescence occurs rapidly

Engineering Contradiction:
Improvemedium composition controlVSAvoidlineage heterogeneity maintenance
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent optimizes specific concentration parameters of chemically defined components to maintain lineage heterogeneity. By carefully adjusting the levels of insulin (5-20 µg/mL), hydrocortisone (0.1-1 µg/mL), epidermal growth factor (0.1-10 ng/mL), and cholera toxin (0.01-0.1 µg/mL), the medium achieves both compositional control and the ability to support diverse epithelial lineages including luminal, basal, and progenitor cells without rapid senescence.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11293008B2Media for culturing epithelial cells
Publication Date: 2022.04.05 RGT UNIV OF CALIFORNIA
  • US11293008B2 patent drawing
  • US11293008B2 patent drawing
  • US11293008B2 patent drawing

AI summary

A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.